CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET ANALYSIS

Central Nervous System Biomarkers Market, by Application (Drug Discovery & Development, Personalized Medicines, Disease Risk Assessment, and Diagnostics), by Disease (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, and Traumatic Brain Injury and Other Neurological Conditions), by End User (Diagnostic Labs, Clinics/Hospitals, and Research Centers), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI2434
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Keys players operating in the global central nervous system biomarkers market include, Thermo fisher scientific, Enzo Biochem Inc., Abiant Inc., EKF Diagnostics Holdings Inc., Abastar MDX Inc., Acumen Pharmaceuticals Inc., Adlyfe Inc., Apitope International, Alseres Pharmaceuticals Inc., Aposense, Banyan Biomarkers, Avid Radiopharmaceuticals Inc., Diagenic ASA, Avacta Group plc., Applied Neurosolutions Inc., Merc & Co. Inc., and Exonhit Therapeutics.